Home > Meetings > 2016 ACCC Award Recipients
Annual Achievement Award
Cancer Support Community
As the largest non-profit, professional, cancer support program in the country, the Cancer Support Community achieves its mission through direct service delivery, research, and advocacy.
The Cancer Support Community reaches cancer patients and their caregivers through online and telephone hotlines, radio programs, and a network of affiliate centers where support groups and complementary medicine programs are offered free of charge. They have developed complimentary educational materials that can be accessed by patients and cancer programs.
Their Research and Training Institute conducts psychosocial, caregiver, and survivorship research. The Cancer Support Community has a voice on Capitol Hill, where they have partnered with ACCC and other advocacy groups to educate legislators on policy issues which impact patient care.
The Cancer Support Community is a wrap-around organization that touches patients, caregivers, oncology professionals, advocacy groups, and policy makers.
Clinical Research Award
Michael O’Connell, MD
Chairman, National Surgical Adjuvant Breast and Bowel Project
Dr. O'Connell serves as associate chairman of the National Surgical Adjuvant Breast and Bowel Project (NSABP). An internationally recognized specialist in the treatment of gastrointestinal tract cancers, he is a prolific researcher who has authored or co-authored more than 200 peer-reviewed journal articles, 150 scientific abstracts and 25 textbook chapters in his field.
Dr. O'Connell has helped direct numerous studies that have resulted in better treatment protocols for cancer of the colon and rectum, and currently is a leader of a national study to determine the efficacy of combining a new anti-angiogenesis therapy, called bevacizumab (Avastin), with standard chemotherapy in patients who have already had surgery for stage II or stage III colon cancer.
Dr. O'Connell was among a select group of cancer specialists invited to the White House in 1996 for President Clinton's announcement of major changes in U.S. Food and Drug Administration (FDA) policy for approval of oncology drugs, and he was selected to participate in the National Dialogue on Cancer chaired by President and Mrs. George H. Bush and the 2001 World Summit Against Cancer in Paris, France.
He is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, and serves on the Board of Directors for the Coalition of National Cancer Cooperative Groups. He is also a member of the National Cancer Institute (NCI) steering committee for gastrointestinal cancer cooperative group clinical trials.
David King Community Clinical Scientist Award
Cary A. Presant, MD, FACP, FASCO
City of Hope Medical Group
San Marino, CA
Dr. Presant is assistant clinical professor, City of Hope Medical Center, and professor of Clinical Medicine, University of Southern California Keck School of Medicine. He currently serves as chairman of the Board of the Medical Oncology Association of Southern California, and he is a past-president of the Association of Community Cancer Centers (ACCC).
Throughout his prolific career, Dr. Presant has been involved in laboratory and clinical investigations. Previously he served as the director of cancer programs at Washington University School of Medicine, the Jewish Hospital of St. Louis, Citrus Valley Health Partners, and St. Vincent Medical Center in Los Angeles.
Dr. Presant has authored more 400 scientific articles. His writing has included book chapters and articles on cancer treatment, cancer detection, chemotherapy, experimental tumor biology, pharmacology, liposomes for cancer diagnosis and therapy, magnetic resonance spectroscopy, and measurement of quality of life in cancer patients.
His leadership has extended to other cancer physicians and organizations throughout the country. Dr. Presant is a past president of the California Division of the American Cancer Society, and past president and chairman of the Board of the Medical Oncology Association of Southern California. He is a past Director of the American Society of Clinical Oncology (ASCO). He served for five years as ASCO’s representative to the House of Delegates of the American Medical Association (AMA), where he was also secretary of the Cancer Caucus and an expert advisor to the Diagnosis and Therapy Technology Assessment Program. The American Medical Association named Dr. Presant to represent them to the United States Commission on Cancer.